July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...
July 10, 2024 — Reviva Pharmaceuticals Holdings, Inc., a late-stage pharmaceutical company developing therapies that ...
July 9, 2024 — The American Heart Association, celebrating 100 years of lifesaving service as the world’s leading ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...
July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...
July 8, 2024 — Pulsed field ablation (PFA) is safe for treating patients with common types of atrial fibrillation (AF) ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
On July 16, Diagnostic and Interventional Cardiology will present a webinar on "Maximizing Structural Heart Workflows ...
July 24, 2024 — During the American Heart Association Basic Cardiovascular Sciences Scientific Sessions 2024, BCVS ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...
July 3, 2024 — Jon Kobashigawa, MD, director of the Heart Transplant Program in the Department of Cardiology in the ...
July 2, 2024 — Biotronik announced the availability of an expanded Maximum Allowed Diameters (MAD) range for the Orsiro ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
July 2, 2024 — The U.S. Food and Drug Administration (FDA) announced that Abbott has issued a correction for its ...

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...
July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...